Article references (51 references )

  1. Schafer G, Blumenthal MJ, Katz AA. Interaction of Human Tumour Viruses with Host Cell Surface Receptors and Cell Entry. Viruses. 2015; 7(5):2592-2617. PubMed | Google Scholar

  2. Rickinson AB, Kieff ED. Epstein-Barr virus In: Knipe DM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, Fields Virology; Fifth ed. Knipe D, Howley P, Eds; Lippincott, Williams and Wilkins. Philadelphia, PA, USA, 2007; pp 2655-2700.

  3. Rickinson AB. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol. 2014; 26:99-115. PubMed | Google Scholar

  4. Kimura H, Kawada J, Ito Y. Epstein-Barr virus- associated lymphoid malignancies: the expanding spectrum of Hematopoietic neoplasms. Nagoya J Med Sci. 2013; 75(3-4): 169-179. PubMed | Google Scholar

  5. Tzellos S, Farrell PJ. Epstein-Barr virus Sequence Variation-Biology and Disease. Pathogens. 2012; 1(2):156-175. PubMed | Google Scholar

  6. Ishtiaq S, Hassan U, Mushtaq S, Akhtar N. Determination of Frequency of Epstein - Barr virus in Non- Hodgkin Lymphomas Using EBV Latent Membrane Protein 1 (EBV-LMP1) Immunohistochemical Staining. Asian Pac J Cancer Prev. 2013; 14(6):3963-3967. PubMed | Google Scholar

  7. Fan H, Kim SC, Chima CO, Israel BF, Lawless KM, Eagan PA, Elmore S, Moore DT, Schichman SA, Swinnen LJ, Gulley ML. Epstein-Barr Viral Load as a Marker of Lymphoma in AIDS Patients. J Med Virol. 2005; 75(1):59-69. PubMed | Google Scholar

  8. Saeed MS. Epstein-Barr virus in Hodgkin's lymphoma-immunohistochemical case series study. Ann Coll Med. 2009; 35(2):93-103. Google Scholar

  9. Hassan R, White LR, Claudio G, Stefanoff CG, de Oliveira DE, Felisbino FE, Klumb CE, Bacchi CE, Seuánez HN, Zalcberg IR. Epstein - Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma. Diagn Pathol. 2006; 1(1):17. Google Scholar

  10. United State National Library of Medecine. Standard Nucleotide BLAST. Accessed janvier 2017

  11. Dojcinov SD, Venkataraman G, Pittaluga G, Wlodarska I, Schrager JA, Raffeld M, Hills RK, Jaffe ES. Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011; 117(18):4726-4735. PubMed | Google Scholar

  12. Cohen JI. Epstein-Barr virus vaccines. Clin Transl Immunology. 2015; 4(1): e32. PubMed | Google Scholar

  13. Qi Z, Han X, Hu J, Wang G, Gao J, Wang X, Liang D. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues. Mol Med Rep. 2013; 7(1):89-92. PubMed | Google Scholar

  14. Aoki R, Karube K, Sugita Y, Nomura Y, Shimizu K, Kimura Y, Hashikawa K, Suefuji N, Kikuchi M, Ohshima K. Distribution of malignant lymphoma in japan: analysis of 2260 cases, 2001-2006. Pathol Int. 2008; 58(3):174-182. PubMed | Google Scholar

  15. Audouin J, Diebold J, Nathwani B, Ishak E, MacLennan K, Mueller-Hermelink HK, Armitage JO, Weisenburger DD. Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt. J Hematop. 2010; 3(1):11-18. PubMed | Google Scholar

  16. Yaqo RT, Hughson MD, Sulayvani FK, Al-Allawi NA. Malignant lymphoma in Northern Iraq: a retrospective analysis of 270 cases according to the world health organisation classification. Indian J Cancer. 2011; 48(4):446-451. PubMed | Google Scholar

  17. Mondal SK, Mandal PK, Samanta TK, Chakaborty S, Roy SD, Roy S. Malignant lymphoma in Eastern India: a retrospective analysis of 455 cases according to World Health Organisation classification. Indian J Med Paediatr Oncol. 2013; 34(4):242-246. PubMed | Google Scholar

  18. Corti M, Villafane M, Bistmans, Narbaitz M, Gilardi. Primary Extranodal Non-Hodgkin Lymphoma of the Head and Neck in Patients with Acquired Immunodeficiency Syndrome: a Clinicopathologic Study of 24 Patients in a single Hospital of infectious Diseases in Argentina. Int Arch of Otorhinolaryngol. 2014; 18(3):260-265. PubMed | Google Scholar

  19. Sun W, Kimball A, Xu Y, Brutkiiewicz R, Strome S, Webb T. Mantle Cell Lymphoma Induced Reduction of Human NKT cells. J Immunol. 2012; 188(1 supplement):162-25. Google Scholar

  20. Yeole BB. Trends in the Incidence of Non-Hodgkin's Lymphoma in India. Asian Pac J Cancer Prev. 2008; 9(3):433-436. PubMed | Google Scholar

  21. Mushtaq S, Akhtar N, Jamal S, Mamoon N, Khadim T, Sarfaraz T, Waqar A. Malignant Lymphomas in Pakistan According to WHO Classification of Lymphoid Neoplasms. Asian Pac J Cancer Prev.2008; 9(2):229-232. PubMed | Google Scholar

  22. Tumwine LK, Orem J, Kerchan P, Byarugaba W, Pileri SA. EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda. Infect Agent Cancer. 2010; 5(1):12. PubMed | Google Scholar

  23. Olu-Edo A, Omoti CE. Hodgkin lymphoma: Clinicopathologic features in Benin City, Nigeria and update on its biology and classification. Niger J of Clin Pract. 2011; 14(4):440-444. Google Scholar

  24. Sharma M, Mannan R, Madhukar M, Navani S, Manjari M, Bhasin TS, Gill SK. Immunohistochemical (IHC) Analysis of Non-Hodgkin's Lymphoma spectrum According to WHO/REAL Classification: a single Centre Experience from Punjab, India. J Clin Diagn Res. 2014; 8(1):46-49. PubMed | Google Scholar

  25. Horesh N, Horowitz NA. Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behaviour and Therapy. Rambam Maimonides Med J. 2014; 5(4):e0038. PubMed | Google Scholar

  26. Padhi S, Paul TR, Challa S, Prayaga AK, Rajappa S, Raghunadharao D, Sarangi R. Primary Extra Nodal Non Hodgkin Lymphoma: a 5 Year Retrospective Analysis. Asian Pac J Cancer Prev. 2012; 13(10):4889-4895. PubMed | Google Scholar

  27. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin Lymphoma (NHL): trends, geographic distribution, and aetiology. Ann Haematol. 2005; 84(1):1-12. Google Scholar

  28. Makar RR, Saji T, Junaid TA. Epstein-Barr virus Expression in Hodgkin's Lymphoma in Kuwait. Pathol and Oncol Res. 2003; 9(3):159. PubMed | Google Scholar

  29. Cartwright RA, Watkins G. Epidemiology of Hodgkin's disease: a review. Haematol Oncol. 2004; 22(1):11-26. PubMed | Google Scholar

  30. Al-Mudallal, Al-Sinjery. Immunohistochemical Expression of Epstein - Barr virus Antigen Latent Membrane Protein-1 and Bcl-2 in Classical Hodgkin Lymphoma. Iraqi J Med Sci. 2012; 10(3):234-242. Google Scholar

  31. Maggioncalda A, Malik N, Shenoy P, Smith M, Sinha R, Flowers CR. Clinical, Molecular, and Environmental Risk Factors for Hodgkin Lymphoma. Adv Haematol. 2011; 2011:1-10. PubMed | Google Scholar

  32. Iliyasu Y, Ayers LW, Liman AA, Waziri GD, Shehu SM. Epstein-Barr virus association with malignant lymphoma subgroups in Zaria, Nigeria. Niger J Surg Sci. 2014; 23(1):6-8. PubMed | Google Scholar

  33. Ashraf MJ, Makarempour A, Monabati A, Azapira N, Khademi B, Hakimzadeh A, Abedi E, Valibeigi B. Comparison between presence of EpsteinBarr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience. Iran Red Crescent Med J. 2012; 14(12):764-770. Google Scholar

  34. Zhang Y, Peng J, Tang Y, He J, Peng J, Zhao Q, He R, Peng X, Gan R. The prevalence of Epstein - Barr virus Infection in Different types and sites of Lymphomas. J Infect Dis. 2010; 63(2):132-135. PubMed | Google Scholar

  35. Chang ET, Zheng T, Lennette ET, Weir EG, Borowitz M, Mann R, Spiegelman D, Mueller NE. Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome positive and negative Hodgkin lymphoma. J Infect Dis. 2004; 189(12):2271-2281. PubMed | Google Scholar

  36. Diepstra A, Imhoff GW, Schaapveld M, Karim-Kos H, Van den Berg A. Poppema S Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. J Clin Oncol. 2009; 27(23):3815-3821. PubMed | Google Scholar

  37. Karnik S, Srinivasan B, Nair S. Hodgkin's lymphoma immunohistochemical features and its association with EBV LMP-1: experience from a Souths Indian hospital. Pathology. 2003; 35(3): 207-211. PubMed | Google Scholar

  38. Katebi M, Sharifi N, Tarhini M, Otrock ZK, Bazarbachi A, Kchour G. Frequency of Epstein-Barr virus expression in various histological subtypes of Hodgkin lymphoma. Histopathology. 2008; 52(6):775-776. PubMed | Google Scholar

  39. Adelusola KA, Titiloye NA, Rotimi O. Epstein-Barr virus latent membrane protein-1 in Hodgkins lymphoma in Nigerians. Afr Health Sci. 2009; 9(3):174-178. PubMed | Google Scholar

  40. García-Cosío M, Santón A, Martín P, Reguero ME, Cristóbal E, Bellas C. Analysis of Epstein-Barr virus strains and variants in classical Hodgkin's lymphoma by laser microdissection. Histol Histopathol. 2008; 23(2):209-217. PubMed | Google Scholar

  41. Bahnassy AA, Zekri AR, Asaad N, El-Houssini S, Khalid HM, Sedky LM, Mokhtar NM. Epstein-Barr viral infection in extranodal lymphoma of head and neck: correlation with prognosis and response to treatment. Histopathology. 2006; 48(5):516-528. PubMed | Google Scholar

  42. Irshaid F, Jaran A, Dilmi F, Tarawneh K, Hadeth R, and Al-Khatib A. Prevalence of Epstein-Barr Virus Latent Membrane Protein-1 in Jordanian Patient with Hodgkin?s Lymphoma and Non-Hodgkin's Lymphoma. J Biol Sci. 2010; 10(6):507-513. Google Scholar

  43. Ai J, Xie, Liu C, Huang Z, Xu J. Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children. Virol J. 2012; 9(1):13. PubMed | Google Scholar

  44. Tinguely M, Bründler M, Gögüs S, Kerl K, Bo B. Epstein-Barr Virus Association in Pediatric Abdominal Non-Hodgkin Lymphomas from Turkey. Arch Immunol Ther Exp (Warsz). 2000; 48(4):317-322. PubMed | Google Scholar

  45. Palma I, Sánchez AE, Jiménez-Hernández E, Alvarez-Rodríguez F, Nava-Frias M, Valencia-Mayoral P, Salinas-Lara C, Velazquez-Guadarrama N, Portilla-Aguilar J, Pena RY, Ramos-Salazar P. Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients With Hodgkin lymphoma: a comparative study in children and adults. Clin Lymphoma Myeloma Leuk. 2013; 13(3):266-272. PubMed | Google Scholar

  46. Yao QY, Croom-Carter DS, Tierney RJ, Habeshaw G, Wilde JT, Hill FG, Conlon C, Rickinson AB. Epidemiology of infection with Epstein-Barr-virus types 1 and 2: Lessons from the study of a T-cell-immunocompromised hemophilic cohort. J Virol. 1998; 72(5):4352-4363. PubMed | Google Scholar

  47. Ibrahim AH, Menasce LP, Pomplun S, Burke M, Bower M, Naresh KN. Epstein-Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)-related B-cell Lymphomas and B-cell post-transplant lymphoproliferative disorders (B-PTLD)-late-onset lymphomas, especially in the HIV setting, are associated with type-B-EBV. Eur J Haematol. 2010; 85(3):227-230. Google Scholar

  48. Simbiri KO, Smith NA, Otieno R, Wohlford E, Daud II, Odaba SP, Middleton F, Rochford R. Epstein-Barr virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Paediatric population. PLoS One. 2015; 10(5):e0125420. Google Scholar

  49. Palser AL, Grayson NE, White RE, Corton C, Correla S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Ricknson AB, Young LS, Farrel PJ, Kellam P. Genome Diversity of Epstein-Barr virus from Multiple Tumour Types and Normal Infection. J Virol. 2015; 89(10):5222-5237. PubMed | Google Scholar

  50. Renzette N, Somasundaran M, Brewster F, Coderre J, Weiss ER, McManus M, Greenough T, Tabak B, Garber M, Kowalik TF, Luzuriaga K. Epstein-Barr virus Latent Membrane Protein 1 Genetic Variability in Peripheral Bloob B cells and Oropharyngeal Fluids. J Virol. 2014; 88(7):3744-3755. PubMed | Google Scholar

  51. Higa M, Kinjo T, Kamiyama K, Iwamasa T, Hamada T, Iyama K. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan. J Clin Pathol. 2002; 55(6):414-423. PubMed | Google Scholar